PD-L2 blockade at the time of allergen challenge, but not at sensitization, increased AHR and eosinophilia, in addition to IL-5 and IL-13 production, but reduced IFN-γ production in the lungs and lymph nodes. This evidence concerns the gene PDCD1LG2 and Increased total eosinophil count.